123 related articles for article (PubMed ID: 1640711)
21. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
Epari K; Cade R
ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
[TBL] [Abstract][Full Text] [Related]
22. Treatment for unresectable or metastatic oesophageal cancer: current evidence and trends.
van Rossum PSN; Mohammad NH; Vleggaar FP; van Hillegersberg R
Nat Rev Gastroenterol Hepatol; 2018 Apr; 15(4):235-249. PubMed ID: 29235549
[TBL] [Abstract][Full Text] [Related]
23. Influence of neoadjuvant chemoradiation on the number and size of analyzed lymph nodes in esophageal cancer.
Bollschweiler E; Besch S; Drebber U; Schröder W; Mönig SP; Vallböhmer D; Baldus SE; Metzger R; Hölscher AH
Ann Surg Oncol; 2010 Dec; 17(12):3187-94. PubMed ID: 20585867
[TBL] [Abstract][Full Text] [Related]
24. Multimodality treatment in the management of esophageal cancer: neoadjuvant chemoradiotherapy followed by transhiatal esophagectomy.
Irwin JF; Waterfield W; Poussin-Rosillo H; Sardi A
Md Med J; 1997 Oct; 46(9):471-76. PubMed ID: 9327648
[TBL] [Abstract][Full Text] [Related]
25. Pre-treatment maximal oesophageal wall thickness is independently associated with response to chemoradiotherapy in patients with T3-4 oesophageal squamous cell carcinoma.
Li SH; Rau KM; Lu HI; Wang YM; Tien WY; Liang JL; Lin WC
Eur J Cardiothorac Surg; 2012 Dec; 42(6):958-64. PubMed ID: 22466694
[TBL] [Abstract][Full Text] [Related]
26. Distant Oncologic Outcome of Patients with Locally Advanced Unresectable and Metastatic Esophageal Cancer after Multimodality Treatment.
Anghel R; Constantinoiu S; Bacinschi X; Gales L; Toma RV; Trifanescu O
Chirurgia (Bucur); 2018; 113(1):116-122. PubMed ID: 29509538
[No Abstract] [Full Text] [Related]
27. [Esophageal carcinoma in an advanced stage. The value of surgery plus radiochemotherapy].
Theisen J; Siewert JR
MMW Fortschr Med; 2002 Jul; 144(27-28):36-8. PubMed ID: 12198876
[No Abstract] [Full Text] [Related]
28. [Therapeutic strategies for advanced respectable esophageal cancer].
Kitagawa Y
Nihon Geka Gakkai Zasshi; 2008 Nov; 109(6):333-7. PubMed ID: 19068714
[TBL] [Abstract][Full Text] [Related]
29. Oesophageal carcinoma: combined chemo- and radiotherapy.
Dehn TC; Jamieson GG; Gill PG
Br J Surg; 1988 Jun; 75(6):621. PubMed ID: 3395833
[No Abstract] [Full Text] [Related]
30. Endoscopic submucosal dissection followed by chemoradiotherapy for superficial esophageal cancer: choice of new approach.
Suzuki G; Yamazaki H; Aibe N; Masui K; Sasaki N; Shimizu D; Kimoto T; Shiozaki A; Dohi O; Fujiwara H; Ishikawa T; Konishi H; Naito Y; Otsuji E; Yamada K
Radiat Oncol; 2018 Dec; 13(1):246. PubMed ID: 30547811
[TBL] [Abstract][Full Text] [Related]
31. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
[TBL] [Abstract][Full Text] [Related]
32. Effectiveness of esophagectomy in patients with thoracic esophageal squamous cell carcinoma receiving definitive radiotherapy or concurrent chemoradiotherapy through intensity-modulated radiation therapy techniques.
Yen YC; Chang JH; Lin WC; Chiou JF; Chang YC; Chang CL; Hsu HL; Chow JM; Yuan KS; Wu ATH; Wu SY
Cancer; 2017 Jun; 123(11):2043-2053. PubMed ID: 28152166
[TBL] [Abstract][Full Text] [Related]
33. [Induction treatment of locally advanced operable cancers of the esophagus. Prognostic significance of the histologic response].
Thomas P; Doddoli C; Giacoia A; Garbe L; Perrier H; Giovannini M; Seitz JF; Hannoun-Levi JM; Giudicelli R; Fuentes P
Ann Chir; 1997; 51(3):222-31. PubMed ID: 9297883
[TBL] [Abstract][Full Text] [Related]
34. Systematic review and meta-analysis on the significance of salvage esophagectomy for persistent or recurrent esophageal squamous cell carcinoma after definitive chemoradiotherapy.
Kumagai K; Mariosa D; Tsai JA; Nilsson M; Ye W; Lundell L; Rouvelas I
Dis Esophagus; 2016 Oct; 29(7):734-739. PubMed ID: 26316181
[TBL] [Abstract][Full Text] [Related]
35. Stage for stage comparison of recurrence patterns after definitive chemoradiotherapy or surgery for oesophageal carcinoma.
Reid TD; Davies IL; Mason J; Roberts SA; Crosby TD; Lewis WG
Clin Oncol (R Coll Radiol); 2012 Nov; 24(9):617-24. PubMed ID: 22386923
[TBL] [Abstract][Full Text] [Related]
36. Advanced Age is Not a Contraindication for Treatment With Curative Intent in Esophageal Cancer.
Voncken FEM; van der Kaaij RT; Sikorska K; van Werkhoven E; van Dieren JM; Grootscholten C; Snaebjornsson P; van Sandick JW; Aleman BMP
Am J Clin Oncol; 2018 Sep; 41(9):919-926. PubMed ID: 28763327
[TBL] [Abstract][Full Text] [Related]
37. Preoperative chemotherapy and radiotherapy for esophageal carcinoma.
Naunheim KS; Petruska P; Roy TS; Andrus CH; Johnson FE; Schlueter JM; Baue AE
J Thorac Cardiovasc Surg; 1992 May; 103(5):887-93; discussion 893-5. PubMed ID: 1569771
[TBL] [Abstract][Full Text] [Related]
38. Improved outcomes in the management of esophageal cancer with the addition of surgical resection to chemoradiation therapy.
McKenzie S; Mailey B; Artinyan A; Metchikian M; Shibata S; Kernstine K; Kim J
Ann Surg Oncol; 2011 Feb; 18(2):551-8. PubMed ID: 20839062
[TBL] [Abstract][Full Text] [Related]
39. Margin involvement and outcome in oesophageal carcinoma: a 10-year experience in a specialist unit.
Mulligan ED; Dunne B; Griffin M; Keeling N; Reynolds JV
Eur J Surg Oncol; 2004 Apr; 30(3):313-7. PubMed ID: 15028315
[TBL] [Abstract][Full Text] [Related]
40. Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa.
Shapiro J; ten Kate FJ; van Hagen P; Biermann K; Wijnhoven BP; van Lanschot JJ
Ann Surg; 2013 Nov; 258(5):678-88; discussion 688-9. PubMed ID: 24096766
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]